Dyslipidemia in patients with chronic kidney disease

Trends in Prevalence of Chronic Kidney Disease in the United States

(2016) Daniel Murphy et al.   ANNALS OF INTERNAL MEDICINE

2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

(2016) Todd J. Anderson et al.   CANADIAN JOURNAL OF CARDIOLOGY

From Lipids to Inflammation

(2016) Michael D. Shapiro et al.   CIRCULATION RESEARCH

Cardiovascular risk prediction in people with chronic kidney disease

(2016) Kunihiro Matsushita et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Cholesterol Metabolism in CKD

(2015) Allison B. Reiss et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Nonstatin Therapies for Management of Dyslipidemia: A Review

(2015) Karen R. Sando et al.   CLINICAL THERAPEUTICS

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report

(2015) Terry A. Jacobson et al.   Journal of Clinical Lipidology

Apolipoprotein E-knockout mice on high-fat diet show autoimmune injury on kidney and aorta

(2014) Yuehai Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Renal and Vascular Protective Effects of Ezetimibe in Chronic Kidney Disease

(2014) Tatsuyori Morita et al.   INTERNAL MEDICINE

Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   CIRCULATION

Benefits and harm of niacin and its analog for renal dialysis patients: a systematic review and meta-analysis

(2013) Yuan-Mei He et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?

(2012) Alexander Tenenbaum et al.   Cardiovascular Diabetology

Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events

(2012) Evangelos C. Rizos et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of Fibrates in Kidney Disease

(2012) Min Jun et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lipid Disorders and Their Relevance to Outcomes in Chronic Kidney Disease

(2011) Nosratola D. Vaziri et al.   BLOOD PURIFICATION

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

(2011) Colin Baigent et al.   LANCET

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

(2010) T. M. E. Davis et al.   DIABETOLOGIA

Omega-3 and Renal Function in Older Adults

(2009) Lauretani F. et al.   CURRENT PHARMACEUTICAL DESIGN

Reduction in cardiovascular risk by sodium-bicarbonated mineral water in moderately hypercholesterolemic young adults

(2009) Ana M. Pérez-Granados et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Lipid and Lipoprotein Metabolism in Chronic Kidney Disease

(2009) George A. Kaysen   JOURNAL OF RENAL NUTRITION

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

(2009) Bengt C. Fellström et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular Risk Factors and Incident Acute Renal Failure in Older Adults: The Cardiovascular Health Study

(2008) A. Mittalhenkle et al.   Clinical Journal of the American Society of Nephrology

Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis

(2008) Guy D. Eslick et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY